Revenue GrowthSharp 2025 revenue acceleration (~108.9%) indicates strong product-market fit and durable demand. Sustained top-line growth enables scale economics across R&D, sales and customer success, supporting continued reinvestment, market-share expansion and a larger addressable revenue base over the medium term.

ProfitabilityHigh gross, operating and net margins show efficient conversion of revenue into profit for a software-application business. Sustainable margins provide internal funding for growth, cushion against pricing pressure, and imply structural advantages such as differentiated product features or cost-efficient delivery models.

Balance Sheet StrengthMaterial improvement in leverage with D/E ~0.06 and healthy ROE indicates strengthened financial flexibility and capital efficiency. Low debt reduces refinancing risk, supports investment or M&A optionality, and makes the business more resilient to cyclical stress over the coming months.

Bears Say

Margin CompressionObserved margin compression versus 2022–2024 suggests rising costs or pricing pressure as the company scales. If this trend persists it will erode operating leverage and cash generation, forcing tougher trade-offs between funding growth and protecting profitability over the medium term.

Cash Flow VolatilityDeclining operating cash flow and lower cash conversion (~0.40 in 2025) plus falling free cash flow in 2024–2025 indicate volatile cash generation. This weakens the company's ability to self-fund expansion, increases dependence on external financing, and raises execution risk if margins or growth slow.

Recent Recovery RiskThe balance sheet recovery is recent after prior negative equity and high leverage. That history heightens the risk that a downturn or operational misstep could reverse improvements, meaning current strength may be less durable without consistent cash generation and disciplined capital management.

153A FAQ

What was Caulis, Inc.’s price range in the past 12 months?

Caulis, Inc. lowest stock price was ¥688.00 and its highest was ¥2888.00 in the past 12 months.

What is Caulis, Inc.’s market cap?

Caulis, Inc.’s market cap is ¥6.63B.

When is Caulis, Inc.’s upcoming earnings report date?

Caulis, Inc.’s upcoming earnings report date is May 14, 2026 which is in 61 days.

How were Caulis, Inc.’s earnings last quarter?

Caulis, Inc. released its earnings results on Feb 13, 2026. The company reported ¥8.88 earnings per share for the quarter, beating the consensus estimate of N/A by ¥8.88.

Is Caulis, Inc. overvalued?

According to Wall Street analysts Caulis, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Caulis, Inc. pay dividends?

Caulis, Inc. pays a Notavailable dividend of ¥4.8 which represents an annual dividend yield of N/A. See more information on Caulis, Inc. dividends here

What is Caulis, Inc.’s EPS estimate?

Caulis, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Caulis, Inc. have?

Caulis, Inc. has 6,528,000 shares outstanding.

What happened to Caulis, Inc.’s price movement after its last earnings report?

Caulis, Inc. reported an EPS of ¥8.88 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.985%.

Which hedge fund is a major shareholder of Caulis, Inc.?

Currently, no hedge funds are holding shares in JP:153A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Caulis, Inc.

Caulis, Inc. (153A) is a biotechnology company specializing in the development of innovative agricultural solutions and biopesticides aimed at enhancing crop productivity and sustainability. The company focuses on harnessing natural plant-based compounds and advanced biotechnological methods to create products that protect crops from pests and diseases while minimizing environmental impact. Caulis, Inc. operates primarily within the agricultural sector, catering to farmers and agricultural businesses seeking eco-friendly alternatives to traditional chemical pesticides.